Acura Pharmaceuticals, Inc. (ACUR) Reports Q4 Loss of $0.03/Share
Tweet
Share
E-mailGet Alerts ACUR Hot Sheet
Price: $0.00 --0%
Financial Fact:
Income (loss) from operations: -2.07M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Income (loss) from operations: -2.07M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) reported Q4 EPS of ($0.03), versus ($0.06) reported last year.
For earnings history and earnings-related data on Acura Pharmaceuticals, Inc. (ACUR) click here.
For earnings history and earnings-related data on Acura Pharmaceuticals, Inc. (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
- Marchex (MCHX) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
